T3 bladder cancer--the case for salvage cystectomy

Area of Science:

• Oncology
• Radiation Oncology

Background:

• Bladder cancer treatment often involves radical radiotherapy or cystectomy.
• Historically, cystectomy was reserved for radiation non-responders or recurrences.

Purpose of the Study:

• To evaluate the long-term outcomes of radical radiotherapy for bladder cancer.
• To identify distinct tumor populations based on radiosensitivity and response to treatment.

Main Methods:

• Retrospective analysis of 704 bladder cancer patients treated with radiotherapy between 1965-1974.
• Minimum 5-year follow-up period to assess survival rates.
• Categorization of tumors based on response to radiotherapy and survival data.

Main Results:

• Overall crude 5-year survival for T3 tumors was 38%.
• Identified two distinct tumor populations: radiosensitive (56% 5-year survival) and radioinsensitive (17% 5-year survival).
• Patients with a good initial response to radiotherapy demonstrated significantly better survival rates.

Conclusions:

• Radiotherapy can achieve comparable survival rates to cystectomy for certain bladder cancer T3 tumors.
• Distinguishing between radiosensitive and radioinsensitive T3 tumors is crucial for treatment planning.
• Cystectomy may not be necessary for patients with a favorable initial response to radical radiotherapy.